Early administration of levosimendan is associated with improved kidney function after cardiac surgery – a retrospective analysis
Open Access
- 18 November 2014
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 9 (1) , 167
Abstract
Several animal studies suggest beneficial effects on kidney function upon administration of levosimendan. As recent data from clinical studies are heterogeneous, we sought to investigate whether levosimendan is associated with improved postoperative kidney function in cardiac surgery patients with respect to timing of its administration. Retrospective, single centre, observational analysis at a university hospital in Berlin, Germany. All adult patients without preoperative renal dysfunction that underwent coronary artery bypass grafting and/or valve reconstruction/replacement between 01/01/2007 and 31/12/2011 were considered for analyses. Out of 1.095 included patients, 46 patients were treated with levosimendan due to a severely reduced left ventricular systolic function preoperatively (LVEF < 35%) and/or clinical signs of a low cardiac output syndrome. Sixty-one percent received the drug whilst in the OR, 39% after postoperative intensive care unit admission. When levosimendan was given immediately after anaesthesia induction, creatinine plasma levels (p = 0.009 for nonparametric analysis of longitudinal data in a two-factorial design) and incidence of postoperative renal dysfunction (67.9% vs. 94.4%; p = 0.033) were significantly reduced in contrast to a later start of treatment. In addition, duration of renal replacement therapy was significantly shorter (79 [35;332] vs. 272 [132;703] minutes; p = 0.046) in that group. Postoperative kidney dysfunction is a common condition in patients under going cardiac surgery. Patients with severely reduced left ventricular function and/or clinical signs of a low cardiac output syndrome who preoperatively presented with a normal kidney function may benefit from an early start of levosimendan administration, i.e. immediately after anaesthesia. Clinicaltrials.gov-ID: NCT01918618 .Keywords
This publication has 42 references indexed in Scilit:
- Renal Effects of Levosimendan: A Consensus ReportCardiovascular Drugs and Therapy, 2013
- Effects of Levosimendan on Renal Function in Patients Undergoing Coronary Artery SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2012
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012European Journal of Heart Failure, 2012
- Aliskiren, ALTITUDE, and the Implications for ATMOSPHEREEuropean Journal of Heart Failure, 2012
- Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB)Journal of Cardiothoracic Surgery, 2009
- Superioridad del sensibilizante al calcio levosimendán comparado con dobutamina en el síndrome de bajo gasto cardiaco postoperatorioRevista Espanola de Cardiologia, 2008
- Levosimendan Improves Renal Function in Patients with Acute Decompensated Heart Failure: Comparison with DobutamineCardiovascular Drugs and Therapy, 2007
- Levosimendan protects against experimental endotoxemic acute renal failureAmerican Journal of Physiology-Renal Physiology, 2006
- LevosimendanDrugs, 2001
- Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamineThe American Journal of Cardiology, 1984